These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 5561605)

  • 61. Rifampicin-ethambutol in the treatment of resistant pulmonary tuberculosis.
    Hertrick C; Ras R; Turri M
    Ger Med Mon; 1971; 1(1):34-7. PubMed ID: 5579591
    [No Abstract]   [Full Text] [Related]  

  • 62. [Advances in the therapy of tuberculosis].
    Corbalán Trumbull G
    Rev Med Chil; 1970 Jan; 98(1):26-30. PubMed ID: 4157372
    [No Abstract]   [Full Text] [Related]  

  • 63. [Experimental study of rifampicin and ethambutol].
    Kozulitsyna TI; Korotaev GA
    Probl Tuberk; 1971; 49(1):64-8. PubMed ID: 5576515
    [No Abstract]   [Full Text] [Related]  

  • 64. [Clinical tolerance of rifampycin administered alone or in combination with other antitubercular drugs].
    Carratù L; Sonaglioni F; Natali P
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):399-410. PubMed ID: 5306592
    [No Abstract]   [Full Text] [Related]  

  • 65. [Etiopathogenic and therapeutical considerations on a case of primary multiple resistance to tuberculostatics].
    Golli V; Gherman M; Tufescu R
    Lille Med; 1973 Mar; 18(3):345-8. PubMed ID: 4727504
    [No Abstract]   [Full Text] [Related]  

  • 66. [Initial provisional record of treatment of relapses of active pulmonary tuberculosis with combined rifomycin, ethambutol and thiocarlide].
    Favez G; Willa C
    Acta Tuberc Pneumol Belg; 1969; 60(3):496-500. PubMed ID: 5392721
    [No Abstract]   [Full Text] [Related]  

  • 67. [The use of ethambutol in the local treatment of tubercular cavities].
    Di Perna A; Iacovelli GC; Merelli B
    G Ital Mal Torace; 1967; 21(6):3-10. PubMed ID: 5616754
    [No Abstract]   [Full Text] [Related]  

  • 68. [Clinico-radiographic dynamics of chronic destructive forms of pulmonary tuberculosis during treatment with ethambutol and rifampicin].
    Koromaev GA; Dmitrieva LI
    Ter Arkh; 1974; 46(9):88-93. PubMed ID: 4439312
    [No Abstract]   [Full Text] [Related]  

  • 69. [Cooperative clinical trials of efficacy of chemotherapy of patients with fibro-cavernous tuberculosis].
    Korotaev GA; Margulis NIu
    Probl Tuberk; 1982 Aug; (8):35-40. PubMed ID: 6755444
    [No Abstract]   [Full Text] [Related]  

  • 70. [Bacteriologic results of treatment with rifampicin and ethambutol administered continuously or intermittently in experimental tuberculosis in white mice].
    Sosnowski W; Tomaszkiewicz L
    Gruzlica; 1973 Mar; 41(3):213-24. PubMed ID: 4696134
    [No Abstract]   [Full Text] [Related]  

  • 71. [New aspects of medical therapy of pulmonary tuberculosis].
    Brouet G
    Acquis Med Recent; 1970; ():31-42. PubMed ID: 5526179
    [No Abstract]   [Full Text] [Related]  

  • 72. [Effectiveness of chemotherapy of chronic forms of pulmonary tuberculosis under hospital conditions].
    Kolesnikov VV; Mikhaĭlov VI; Matviiakina TS
    Probl Tuberk; 1980 Mar; (3):41-4. PubMed ID: 7393892
    [No Abstract]   [Full Text] [Related]  

  • 73. Haematological changes during intermittent treatment with rifampicin.
    Wislawska-Orlowska B; Pniewski T
    Scand J Respir Dis Suppl; 1973; 84():94-7. PubMed ID: 4522080
    [No Abstract]   [Full Text] [Related]  

  • 74. [Retreatment of tuberculosis resistent to 1st and 2d line drugs with AMP rifomycin and ethambutol].
    Ibarra JP; Pińeyro J; Mello Aguerre M; Pintos Fuentes R; Trenchi A; Freijeiro R; Bazerque E
    Hoja Tisiol; 1970; 27(1):98-117. PubMed ID: 5524669
    [No Abstract]   [Full Text] [Related]  

  • 75. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A; Rahman M; Raviglione M; Bustreo F
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG; Esanbaev DE; Kirina SB
    Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983
    [No Abstract]   [Full Text] [Related]  

  • 77. Capreomycin, ethambutol and rifampicin in apparently incurable pulmonary tuberculosis.
    Hellström PE; Repo UK
    Scand J Respir Dis Suppl; 1969; 69():69-74. PubMed ID: 4906377
    [No Abstract]   [Full Text] [Related]  

  • 78. [Preliminary report on the results of retreatment with rifomycin AMP and ethambutol].
    Ibarra JP; Costa de Mello B; Mazza de Pratto N
    Hoja Tisiol; 1969; 26(1):113-26. PubMed ID: 5401724
    [No Abstract]   [Full Text] [Related]  

  • 79. [New methods in the treatment of pulmonary tuberculosis].
    Coury C; Constans P
    Therapeutique; 1972 Jan; 48(1):43-6. PubMed ID: 5046368
    [No Abstract]   [Full Text] [Related]  

  • 80. [Treatment of advanced and complicated variants of osteoarticular tuberculosis with rifampin and ethambutol].
    Suleĭmanov I; Prosvirova LA; Umarov B; Beliakova NK
    Probl Tuberk; 1981 Dec; (12):49-52. PubMed ID: 7335634
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.